Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
5.88
+0.04 (0.68%)
May 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Commercial Products | 497.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Countermeasures Products | 447.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services | 78.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items | 26.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items Growth | -36.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Government - Medical Countermeasures and Commercial Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Development and Manufacturing Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Development and Manufacturing Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nasal Naloxone Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nasal Naloxone Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Development and Manufacturing - Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Development and Manufacturing - Leases | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anthrax Vaccines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anthrax Vaccines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ACAM2000 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ACAM2000 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Other | 217.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 163.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 607.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -31.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | 224.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | 50.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 217.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 163.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|